J 2019

Efficient and robust preparation of tyrosine phosphorylated intrinsically disordered proteins

BRÁZDA, Pavel, Ondrej ŠEDO, Karel KUBÍČEK and Richard ŠTEFL

Basic information

Original name

Efficient and robust preparation of tyrosine phosphorylated intrinsically disordered proteins

Authors

BRÁZDA, Pavel (203 Czech Republic, belonging to the institution), Ondrej ŠEDO (203 Czech Republic, belonging to the institution), Karel KUBÍČEK (203 Czech Republic, belonging to the institution) and Richard ŠTEFL (203 Czech Republic, guarantor, belonging to the institution)

Edition

BioTechniques, UNITED HOUSE, 2 ALBERT PL, LONDON N3 1QB, FUTURE SCI LTD, 2019, 0736-6205

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

RIV identification code

RIV/00216224:14740/19:00107820

Organization

Středoevropský technologický institut – Repository – Repository

UT WoS

000475967900005

Keywords in English

C-terminal domain; co-expression; CTD; IDP; intrinsically disordered proteins; phosphorylation; purification; RNA polymerase II; TRANSCRIPTION TERMINATION; LARGEST SUBUNIT; CELL-CYCLE; KINASE; STRATEGIES; SEMISYNTHESIS

Links

GA15-17670S, research and development project. GA18-11397S, research and development project. LQ1601, research and development project. 649030, interní kód Repo. CIISB, large research infrastructures.
Změněno: 15/10/2024 00:50, RNDr. Daniel Jakubík

Abstract

V originále

Intrinsically disordered proteins (IDPs) are subject to post-translational modifications. This allows the same polypeptide to undertake different interaction networks with different consequences, ranging from regulatory signalling networks to formation of membraneless organelles. We report a robust method for co-expression of modification enzyme and SUMO-tagged IDP with subsequent purification procedure allowing production of modified IDP. The robustness of our protocol is demonstrated on a challenging system, RNA polymerase II C-terminal domain (CM), that is a low-complexity repetitive region with multiple phosphorylation sites. In vitro phosphorylation approaches fail to yield multiple-site phosphorylated CTD, whereas our in vivo protocol allows to rapidly produce near homogeneous phosphorylated CTD at a low cost. These samples can be used in functional and structural studies.

Files attached